Aquestive Therapeutics, Inc. AQST Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s change in accrued liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported change in accrued liabilities of -$2.8M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s change in accrued liabilities decreased by 1.0% year-over-year, from -$2.78M to -$2.8M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.